Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial

British Journal of Dermatology

Volumn 137, Issue 4, 1997, Pages 581-586

  Veien, N K ^a   Bjerke, J R ^b   Rossmann Ringdahl, I ^c   Jakobsen, H B ^d  

^a Dermatology Clinic Aalborg   (Denmark)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d Nycomed Denmark   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TACALCITOL;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHEMA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CALCITRIOL; CALCIUM; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0030807812     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03790.x     Document Type: Article

References (11)

1. 3 analogue, 1α, 24-dihydroxycholecalciferol. Br J Dermatol 1986; 115: 431-3.
2. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 1994; 131: 57-63.
3. Scarpa C. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis. J Eur Acad Dermatol Venereol 1996; 6: 142-6.
4. Baadsgaard O, Traulsen J, Roed-Petersen J, Jakobsen HB. Optimal concentration of tacalcitol in once-daily treatment of psoriasis. J Dermatol Treat 1995; 6: 145-50.
5. van de Kerkhof PCM, Werfel T, Haustein UF et al. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 1996; 135: 758-65.
6. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch Dermatol 1989; 125: 1647-52.
7. Kragballe K, Gjertsen BT, de Hoop D et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337: 193-6.
8. Cunliffe WJ, Berth-Jones J, Claudy A et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26: 736-43.
9. Chuang-Stein C. Summarizing laboratory data with different reference ranges in multi-center clinical trials. Drug Info J 1992; 26: 77-84.
10. 3 for the treatment of psoriasis. Review of the literature. Eur J Deematol 1993; 3: 255-61.
11. Nishimura M, Makino Y, Matugi H. Tacalcitol ointment for psoriasis. Acta Derm Venereol (Stockh) 1994; 186 (Suppl.): 166-8.